arrow
L

Lisa Paschold

department of internal medicine iv
H指数:15
被引数:2,080

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

OncoMimic peptide-based immunotherapy EO2401 induces shared T cell clusters in patients with adrenal cancer
2026-07-060
OA
Donor Demographics and Leukopak Consistency: Yield and Composition as Operational Benchmarks for Cell-Therapy Starting Materials

供体人口统计学与白细胞包(Leukopak)一致性:产量和组成作为细胞治疗起始材料的质量控制基准

2026-05-150
PRE
UV1 vaccination in pembrolizumab-treated patients with recurrent or metastatic head and neck cancer: A randomized multicenter phase 2 trial

UV1疫苗接种在经帕博利珠单抗治疗、患有复发性或转移性头颈癌患者中的效果:一项随机多中心II期临床试验

Med
IF11.8
2025-04-110
PRE
Trifluridine/Tipiracil Based Chemoradiation in locally Advanced Rectal Cancer: The Phase I/II TARC Trial

局部晚期直肠癌中基于三氟尿苷/替匹拉西的放化疗: I/II期TARC试验

2025-03-010
OAAI
A20 haploinsufficiency disturbs immune homeostasis and drives the transformation of lymphocytes with permissive antigen receptors

A20单倍不足会干扰免疫稳态,并通过允许的抗原受体驱动淋巴细胞的转化

2024-08-230
OAAI
B cells expressing mutated IGHV1-69-encoded antigen receptors related to virus neutralization show lymphoma-like transcriptomes in patients with chronic HCV infection

表达与病毒中和相关的突变IGHV1-69-encoded抗原受体的b细胞在慢性HCV感染患者中显示淋巴瘤样转录组

2024-08-010
OAAI
SARS-CoV-2 vaccination may mitigate dysregulation of IL-1/IL-18 and gastrointestinal symptoms of the post-COVID-19 condition

SARS-CoV-2疫苗接种可以减轻IL-1/IL-18失调和post-COVID-19状况的胃肠道症状

2024-02-053
OAAI
Mutation-specific CAR T cells as precision therapy for IGLV3-21R110 expressing high-risk chronic lymphocytic leukemia

突变特异性CAR T细胞精准治疗高危慢性淋巴细胞白血病IGLV3-21R110

2024-02-024
OAAI
First-line treatment of unresectable or metastatic HER2 positive esophagogastric adenocarcinoma: liquid biomarker analysis of the phase 2 INTEGA trial

不可切除或转移性HER2阳性食管胃腺癌的一线治疗: INTEGA 2期试验的液体生物标志物分析

2023-06-163
OAAI
Translational analysis and final efficacy of the AVETUX trial - Avelumab, cetuximab and FOLFOX in metastatic colorectal cancer
2022-12-2017
OAAI
The IL-1?, IL-6, and TNF cytokine triad is associated with post-acute sequelae of COVID-19

IL-1?,IL-6和TNF细胞因子三联体与新型冠状病毒肺炎的急性后遗症有关

2022-06-01240
OAAI